Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice-Reference-Cited by-同舟云学术

Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice

Published:2017-08-26 Issue:4 Volume:66 Page:1067-1082
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bian Yingjie¹²^ORCID,Zhang Zheng³,Sun Zhichen¹²,Zhao Juanjuan³,Zhu Danming⁴,Wang Yang⁵,Fu Sherry⁵,Guo Jingya¹,Liu Longchao¹²,Su Lishan⁶,Wang Fu-Sheng⁷,Fu Yang-Xin¹⁵,Peng Hua¹

Affiliation:

1. IBP-UT Group for Immunotherapy; CAS Key Laboratory for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences; Beijing China

2. University of Chinese Academy of Sciences; Beijing China

3. Research Center for Biological Therapy, Beijing 302 Hospital; Beijing China

4. Alphamab Co. Ltd.; Suzhou China

5. Department of Pathology; UT Southwestern Medical Center; Dallas TX

6. Lineberger Comprehensive Cancer Center; University of North Carolina at Chapel Hill; Chapel Hill NC

7. Treatment and Research Center for Infectious Diseases, 302 Hospital of Chinese PLA; Beijing China

Funder

National Key Basic Research Program of China

National Grand Program on Key Infectious Diseases

National Natural Science Foundation of China

NIH

Publisher

Wiley

Subject

Hepatology

Reference43 articles.

1. Hepatitis B virus infection-natural history and clinical consequences;Ganem;N Engl J Med,2004

2. Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen;Dienstag;Ann Intern Med,1982

3. HBsAg inhibits IFN-α production in plasmacytoid dendritic cells through TNF-α and IL-10 INDUCTION IN MOnocytes;Shi;PLoS One,2012

4. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans;Duan;J Clin Immunol,2004

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticle-encapsulated DOCK11-siRNA efficiently reduces hepatitis B virus cccDNA level in infected mice;Molecular Therapy - Methods & Clinical Development;2024-09

2. The Hepatitis B Virus PreS1/HBsAg Ratio Is a Predictive Marker for the Occurrence of Hepatocellular Carcinoma;Livers;2024-08-02

3. Contriving a novel of CHB therapeutic vaccine based on IgV_CTLA-4 and L protein via immunoinformatics approach;Journal of Biomolecular Structure and Dynamics;2023-07-09

4. Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B;Virus Genes;2023-06-12

5. The Multiple Facets and Disorders of B Cell Functions in Hepatitis B Virus Infection;Journal of Clinical Medicine;2023-03-02